Publications by authors named "Tujia Chen"

Background: Programmed cell death protein 1 (PD-1) inhibitors are commonly used worldwide for the management of non-small cell lung cancer (NSCLC). However, it remains unclear whether pembrolizumab and sintilimab, two of the most widely used PD-1 inhibitors in China, have significantly different effects on patients with NSCLC. A multicenter retrospective cohort study was designed and implemented using propensity-score matching (PSM) analysis to compare the effectiveness and safety profiles of pembrolizumab and sintilimab in patients with advanced NSCLC undergoing comprehensive therapy.

View Article and Find Full Text PDF
Article Synopsis
  • CDK4/6 inhibitors dalpiciclib and abemaciclib are approved in China as first-line treatments for advanced hormone receptor-positive and HER2-negative breast cancer in postmenopausal women.
  • A Markov model was used to evaluate the cost-effectiveness of dalpiciclib combined with a non-steroidal aromatase inhibitor (NSAI) versus abemaciclib plus NSAI, using data from clinical trials.
  • Dalpiciclib plus NSAI resulted in 4.27 more quality-adjusted life-years (QALYs) and had a cost-effectiveness probability of 77.42%, indicating it is a more cost-effective option for treatment compared to abemaciclib plus NSAI
View Article and Find Full Text PDF

A PHP Error was encountered

Severity: Warning

Message: fopen(/var/lib/php/sessions/ci_sessionmtrorl26d6v2balelehf2cvqkugmoteh): Failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 177

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/lib/php/sessions)

Filename: Session/Session.php

Line Number: 137

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once